Physical Poster + E-Poster Presentation 34th Lorne Cancer Conference 2022

Revolutionizing Gene Delivery from Design to Therapy (#158)

Thomas Leung 1
  1. VectorBuilder Inc., Victoria, Australia

VectorBuilder: Revolutionizing Gene Delivery from Design to Therapy 


VectorBuilder is a rapidly growing biotechnology company specialising in advanced genetic engineering solutions for research and medicine. In particular, VectorBuilder has established itself as the global leader in a range of products and services related to gene delivery, including vector design and optimisation, vector cloning, virus packaging, library construction and screening, stable cell line generation, and GMP manufacturing of clinical-grade plasmids, mRNAs, proteins and viruses. 


One highlight of VectorBuilder's innovative solutions is its revolutionary online platform for designing and ordering custom vectors, available at https://www.vectorbuilder.com. This award-winning platform has become highly popular with researchers around the world and has grown into an industry standard for its rich functionalities, extensive experimental validations, and easy-to-use graphical interface. By leveraging the popularity of this platform, VectorBuilder has built a comprehensive portfolio of offerings covering virtually all gene delivery needs from bench to bedside.


VectorBuilder can fulfill the full range of plasmid design, cloning and manufacturing needs throughout the gene therapy drug development pipeline. Relying on our revolutionary vector design platform and extensive experience, we can provide optimal vector designs tailored to a wide range of research and clinical needs. 


In addition, VectorBuilder has extensive expertise in producing many different types of viruses. We can provide viruses of different scales and quality attributes to meet the full range of demands along the gene therapy drug development pipeline. We have established and validated platform technologies for large-scale GMP manufacturing of adeno-associated virus (AAV) and lentivirus. We also have experience producing other types of viral vectors such as adenovirus, MMLV, herpes simplex virus (HSV), and vesicular stomatitis virus (VSV). 


We can produce both plasmids and viruses in several grades that cover different downstream applications including drug discovery research, pre-clinical studies, clinical trials and commercialization.